← Evidence map

ArticleEuropean journal of haematology2025

Prognostic Value of Molecular Genetic Measurable Residual Disease (MRD) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10.

Emma Steidel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 40803346